Dr. Shann Kerner works with emerging, mid-sized and public biotechnology, pharmaceutical and medical device companies and with universities, advising them on the creation, protection and leveraging of their patent portfolios.

She also focuses on patent litigation support; technical support for commercial land antitrust litigation, IP due diligence in connection with venture capital IPOs and mergers and acquisitions; internal IP audits; as well as analyses relating to patentability, freedom-to-operate, inventorship, derivation, validity and subject matter landscape.

Shann’s areas of technical concentration include molecular biology, microbiology, biochemistry, immunology, virology, cell biology, and plant biology.

Her clients are in the fields of cancer and inflammatory disorders, early and late stage disease diagnostics and therapeutics, gastroenterology, orthopaedics ,neurology, stem cells, immunology, agribiotech, animal health, nanotechnology, ophthalmology, antioxidants, pharmaceuticals, antioxidants and medical devices.